Table 1.
Baseline demographic characteristics of CHR, HC and CHR-negative participants.
Characteristic | CHRs (N = 114) |
HCs (N = 49) |
CHR-Ns (N = 39) |
df | F/ X2 | p | Post-hoc contrast |
---|---|---|---|---|---|---|---|
Age (years), M ± SD | 21.68 ± 4.48 | 22.49 ± 3.57 | 22.74 ± 4.59 | 2 | F = 1.16 | 0.31 | – |
Gender, Female (%) | 85 (74.5%) | 33 (67.3%) | 26 (66.6%) | 2 | F = 0.68 | 0.50 | – |
Years of education, M ± SD | 15.27 ± 3.24 | 16.63 ± 3.03 | 16.46 ± 3.44 | 2 | F = 3.94 | 0.02 | HCs vs CHRs |
GAF, median (range) | 58 (21–91) | 89 (68–97) | 70 (43–84) | 2 | F = 164.53 | <0.001 | HCs vs CHR-Ns vs CHRs |
CRH-Diagnosis | |||||||
CAARMS | 35 | ||||||
SPI-A | 28 | ||||||
CAARMS/SPI-A | 51 | ||||||
CAARMS-Positive Severity, median (range) | 28 (0–72) | 0 (0−12) | 6 (0–24) | 2 | F = 154.60 | <0.001 | HCs vs CHR-Ns vs CHRs |
GF: Social, median (range) | 8 (5–10) | 9 (8–9) | 8 (6–9) | 2 | F = 61.35 | <0.001 | HCs vs CHR-Ns vs CHRs |
GF: Role, median (range) | 8 (4–9) | 9 (5–9) | 8 (5–9) | 2 | F = 27.79 | <0.001 | HCs vs CHR-Ns vs CHRs |
PAS, median (range) | |||||||
Childhood | 3 (0–16) | 1 (0–6) | 2 (0–6) | 2 | F = 24.70 | <0.001 | HCs vs CHR-Ns vs CHRs |
Early adolescence | 6 (0−22) | 2 (0–8) | 4 (0–14) | 2 | F = 33.44 | <0.001 | HCs vs CHR-Ns vs CHRs |
Late adolescence | 5 (0−20) | 2 (0−10) | 4 (0−13) | 2 | F = 19.66 | <0.001 | HCs vs CHR-Ns, HCs vs CHRs |
Medication, N (%) | 54 (47.3%) | 17 (43.5%) | 2 | X2 = 23.31 | <0.001 | HCs vs CHRs, HCs vs CHR-Ns | |
None | 60 (52.6%) | 22 (56.4%) | |||||
Anti-psychotic | 1 (0.8%) | 0 (0%) | 2 | F = 0.38 | 0.68 | – | |
Mood stabiliser | 3 (2.6%) | 0 (0%) | 2 | X2 = 2.33 | 0.31 | – | |
Anti-depressant | 36 (31.5%) | 13 (33.3%) | 2 | X2 = 15.32 | <0.001 | HCs vs CHRs, HCs vs CHR-Ns | |
Other | 26 (22.8%) | 6 (15%) | 2 | X2 = 6.75 | 0.034 | HCs vs CHRs | |
Diagnosis, N (%) | 103 (90.3%) | 23 (58.9%) | 2 | X2 = 101.0 | <0.001 | HCs vs CHR-Ns vs CHRs | |
Anxiety disorders | 94 (82.4%) | 17 (43.5%) | 2 | X2 = 92.00 | <0.001 | HCs vs CHR-Ns vs CHRs | |
Mood disorders | 70 (61.4%) | 11 (28.2%) | 2 | X2 = 56.36 | <0.001 | HCs vs CHR-Ns vs CHRs | |
Eating disorders | 12 (10.5%) | 1 (2.5%) | 2 | X2 = 7.36 | 0.025 | HCs vs CHRs | |
Suicide Risk | 57 (50%) | 9 (23%) | 2 | X2 = 37.59 | <0.001 | HCs vs CHRs vs CHR-Ns | |
Alcohol Dependence/Abuse | 32 (28.07%) | 10 (25.6%) | 2 | X2 = 11.93 | 0.003 | HCs vs CHRs, HCs vs CHR-Ns | |
Substance Dependence/Abuse | 15 (13.1%) | 3 (7.6%) | 2 | X2 = 7.36 | 0.025 | HCs vs CHRs, | |
Obsessive Compulsive Disorder (OCD) | 16 (14.03%) | 0 (0%) | 2 | X2 = 13.34 | 0.001 | HCs vs CHRs vs CHR-Ns | |
Post-Traumatic Stress Disorder (PTSD) | 11 (9.6%) | 1 (2.5%) | 2 | X2 = 6.66 | 0.036 | HCs vs CHRs | |
BACS (M/SD) | |||||||
Verbal Memory | −0.54/ 1.84 | 0.12/ 1.37 | −0.24/ 1.38 | 2 | F = 2.80 | 0.06 | – |
Motor Speed | −0.72/ 1.92 | 0.07/ 1.21 | −0.54/ 1.56 | 2 | F = 3.75 | 0.02 | HCs vs CHRs |
Processing Speed | −0.03/ 1.79 | 0.16/ 1.54 | −0.12/ 1.53 | 2 | F = 0.37 | 0.68 | – |
Verbal Fluency | 0.09/ 1.36 | 0.41/ 1.37 | 0.30/ 1.07 | 2 | F = 1.17 | 0.31 | – |
Executive Function | −0.07/ 1.89 | −0.05/ 1.41 | 0.12/ 1.02 | 2 | F = 0.21 | 0.80 | – |
Working Memory | −0.37/ 1.51 | −0.34/ 1.23 | −0.37/ 1.98 | 2 | F = 0.007 | 0.99 | – |
BACS Composite | −0.46/ 1.58 | 0.11/ 1.10 | −0.21/ 0.99 | 2 | F = 3.13 | 0.04 | HCs vs CHRs |